The leads of the FoCUS Research Teams, Strategic Director Mark Trusheim,  Research Advisor Casey Quinn, Director of Simulation & Policy Research Daniel Mytelka, and Director of Drug Development Pipeline Research Colin Young, were recently interviewed by Managed Health Care Connect on the challenges and the opportunities in payment models for upcoming Gene Therapies.

Read the article Innovating Payment Models For Gene Therapy on Managed Health Care Connect